

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.55158073 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.55158073 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.53342361 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.39608431 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.39608431 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 5.30006173 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.88814623 |
| 8 | cysteine metabolic process (GO:0006534) | 4.77420411 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 4.61697108 |
| 10 | exogenous drug catabolic process (GO:0042738) | 4.54432126 |
| 11 | urea metabolic process (GO:0019627) | 4.50821253 |
| 12 | urea cycle (GO:0000050) | 4.50821253 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 4.39957615 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.37983287 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.37575798 |
| 16 | low-density lipoprotein particle remodeling (GO:0034374) | 4.30611515 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.29701881 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.29701881 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.29701881 |
| 20 | blood coagulation, intrinsic pathway (GO:0007597) | 4.28955385 |
| 21 | protein carboxylation (GO:0018214) | 4.25813900 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.25813900 |
| 23 | lysine metabolic process (GO:0006553) | 4.24925992 |
| 24 | lysine catabolic process (GO:0006554) | 4.24925992 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.24044697 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.21435252 |
| 27 | negative regulation of protein activation cascade (GO:2000258) | 4.21300635 |
| 28 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.17119382 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.17035391 |
| 30 | reverse cholesterol transport (GO:0043691) | 4.15611697 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.14083353 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.11586179 |
| 33 | intestinal cholesterol absorption (GO:0030299) | 4.09649553 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.09181136 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.09181136 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.09181136 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.09060215 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.08713585 |
| 39 | plasma lipoprotein particle clearance (GO:0034381) | 4.06744651 |
| 40 | drug metabolic process (GO:0017144) | 4.01935576 |
| 41 | complement activation, alternative pathway (GO:0006957) | 3.99016547 |
| 42 | bile acid metabolic process (GO:0008206) | 3.89637210 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 3.88903777 |
| 44 | negative regulation of hemostasis (GO:1900047) | 3.88903777 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 3.86071342 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 3.83037126 |
| 47 | cholesterol efflux (GO:0033344) | 3.82932254 |
| 48 | regulation of protein activation cascade (GO:2000257) | 3.82898798 |
| 49 | drug catabolic process (GO:0042737) | 3.82021215 |
| 50 | phospholipid efflux (GO:0033700) | 3.81203779 |
| 51 | phenylpropanoid metabolic process (GO:0009698) | 3.80849522 |
| 52 | cellular glucuronidation (GO:0052695) | 3.80841766 |
| 53 | bile acid and bile salt transport (GO:0015721) | 3.80477053 |
| 54 | negative regulation of coagulation (GO:0050819) | 3.78201071 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.76262179 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.76262179 |
| 57 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.75141933 |
| 58 | flavonoid metabolic process (GO:0009812) | 3.73468825 |
| 59 | negative regulation of fibrinolysis (GO:0051918) | 3.73327640 |
| 60 | negative regulation of sterol transport (GO:0032372) | 3.72775025 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 3.72775025 |
| 62 | regulation of plasminogen activation (GO:0010755) | 3.71276015 |
| 63 | aromatic amino acid family metabolic process (GO:0009072) | 3.70241157 |
| 64 | omega-hydroxylase P450 pathway (GO:0097267) | 3.69913155 |
| 65 | drug transmembrane transport (GO:0006855) | 3.68904650 |
| 66 | intestinal absorption (GO:0050892) | 3.68550222 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.68399486 |
| 68 | aldehyde catabolic process (GO:0046185) | 3.67351557 |
| 69 | negative regulation of lipase activity (GO:0060192) | 3.66572746 |
| 70 | daunorubicin metabolic process (GO:0044597) | 3.65391623 |
| 71 | polyketide metabolic process (GO:0030638) | 3.65391623 |
| 72 | doxorubicin metabolic process (GO:0044598) | 3.65391623 |
| 73 | glucuronate metabolic process (GO:0019585) | 3.64700688 |
| 74 | uronic acid metabolic process (GO:0006063) | 3.64700688 |
| 75 | negative regulation of wound healing (GO:0061045) | 3.61051655 |
| 76 | regulation of complement activation (GO:0030449) | 3.61013244 |
| 77 | serine family amino acid catabolic process (GO:0009071) | 3.59050767 |
| 78 | regulation of fibrinolysis (GO:0051917) | 3.58019165 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.54394227 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 3.53976319 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.53140571 |
| 82 | lipoprotein metabolic process (GO:0042157) | 3.51352978 |
| 83 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.48203214 |
| 84 | tyrosine metabolic process (GO:0006570) | 3.46149482 |
| 85 | negative regulation of complement activation (GO:0045916) | 3.41999505 |
| 86 | ethanol metabolic process (GO:0006067) | 3.41489241 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 3.41088926 |
| 88 | protein activation cascade (GO:0072376) | 3.40515120 |
| 89 | acute-phase response (GO:0006953) | 3.38775453 |
| 90 | alpha-amino acid catabolic process (GO:1901606) | 3.38529756 |
| 91 | short-chain fatty acid metabolic process (GO:0046459) | 3.37810238 |
| 92 | glutamate metabolic process (GO:0006536) | 3.37552688 |
| 93 | sterol homeostasis (GO:0055092) | 3.35019956 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.34898247 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.33550791 |
| 96 | lipoprotein transport (GO:0042953) | 3.33406725 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 3.31328481 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.31010435 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.30799555 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.30799555 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.29143686 |
| 102 | cellular amino acid catabolic process (GO:0009063) | 3.29124271 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.29036275 |
| 104 | protein-lipid complex assembly (GO:0065005) | 3.27873305 |
| 105 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.26941922 |
| 106 | hormone catabolic process (GO:0042447) | 3.26487720 |
| 107 | 2-oxoglutarate metabolic process (GO:0006103) | 3.23737632 |
| 108 | complement activation, classical pathway (GO:0006958) | 3.22807958 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.21606643 |
| 110 | ethanol oxidation (GO:0006069) | 3.20254662 |
| 111 | angiotensin maturation (GO:0002003) | 3.18873523 |
| 112 | positive regulation of steroid metabolic process (GO:0045940) | 3.18355951 |
| 113 | fatty acid oxidation (GO:0019395) | 3.16867240 |
| 114 | fibrinolysis (GO:0042730) | 3.16039035 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 3.15920075 |
| 116 | cholesterol transport (GO:0030301) | 3.14092194 |
| 117 | sterol transport (GO:0015918) | 3.14092194 |
| 118 | ketone body metabolic process (GO:1902224) | 3.13993065 |
| 119 | fatty acid beta-oxidation (GO:0006635) | 3.13857772 |
| 120 | low-density lipoprotein particle clearance (GO:0034383) | 3.13074067 |
| 121 | lipid oxidation (GO:0034440) | 3.12721214 |
| 122 | L-ascorbic acid metabolic process (GO:0019852) | 3.12706021 |
| 123 | regulation of humoral immune response (GO:0002920) | 3.12596062 |
| 124 | alkaloid metabolic process (GO:0009820) | 3.12332932 |
| 125 | drug transport (GO:0015893) | 3.11192934 |
| 126 | urate metabolic process (GO:0046415) | 3.08637479 |
| 127 | xenobiotic catabolic process (GO:0042178) | 3.06267714 |
| 128 | response to nitrosative stress (GO:0051409) | 3.04524118 |
| 129 | lipid homeostasis (GO:0055088) | 3.02729753 |
| 130 | carboxylic acid catabolic process (GO:0046395) | 3.02605482 |
| 131 | organic acid catabolic process (GO:0016054) | 3.02605482 |
| 132 | heme transport (GO:0015886) | 3.02319058 |
| 133 | monocarboxylic acid catabolic process (GO:0072329) | 3.01155295 |
| 134 | aspartate family amino acid catabolic process (GO:0009068) | 3.00750083 |
| 135 | diacylglycerol metabolic process (GO:0046339) | 2.99664705 |
| 136 | regulation of apoptotic cell clearance (GO:2000425) | 2.98874947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.72010573 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.35756561 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.57403446 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.25405845 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.68800589 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.14684770 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.03144938 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.45264933 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.07619561 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.53851878 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.20169622 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.19459904 |
| 13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16912290 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.13427727 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.06360375 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.98222585 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96307369 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.93198407 |
| 19 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.76738323 |
| 20 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.69515966 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68597069 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67563613 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.66627293 |
| 24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63371940 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.61386918 |
| 26 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.61067783 |
| 27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.60386890 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53714926 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51416784 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45999967 |
| 31 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.45601485 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45565007 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44279563 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35098465 |
| 35 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33405094 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32275779 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32275779 |
| 38 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.30750833 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25625734 |
| 40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25146077 |
| 41 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24822524 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21953534 |
| 43 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21321294 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20927331 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20843208 |
| 46 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20426120 |
| 47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18226258 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18218771 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17308680 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17206427 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16729773 |
| 52 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14939668 |
| 53 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13627893 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09680822 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07415516 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03878146 |
| 57 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03751353 |
| 58 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03751353 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03638865 |
| 60 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.01658366 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01108854 |
| 62 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00782004 |
| 63 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98465038 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93700914 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93532208 |
| 66 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93476732 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92801480 |
| 68 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91721221 |
| 69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91205159 |
| 70 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89362290 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88923102 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88576116 |
| 73 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87637233 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86849559 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86795063 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84166274 |
| 77 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83877501 |
| 78 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83753930 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82569114 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82342650 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82021773 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82006106 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80944116 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80799692 |
| 85 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80328427 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80258663 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79857442 |
| 88 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77890760 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76738237 |
| 90 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76168349 |
| 91 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76158851 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.76069455 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.73980495 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73412211 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72508177 |
| 96 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.70877285 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70056725 |
| 98 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.70011151 |
| 99 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.68294190 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.68231554 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.67668411 |
| 102 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.67514316 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67370999 |
| 104 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66888659 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66879679 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.66315618 |
| 107 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.65656573 |
| 108 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65385678 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.64427278 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.64371915 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 0.64257864 |
| 112 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63988504 |
| 113 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.63927598 |
| 114 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.63229533 |
| 115 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.62768435 |
| 116 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.62757261 |
| 117 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.61669484 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.61478227 |
| 119 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.61219929 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.60460952 |
| 121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.60269644 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59260678 |
| 123 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.58160427 |
| 124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.57649530 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57345573 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.57058586 |
| 127 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56954406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.72774902 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.63232686 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.05467194 |
| 4 | MP0005365_abnormal_bile_salt | 4.74304505 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.22028384 |
| 6 | MP0003252_abnormal_bile_duct | 3.54510156 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.42654287 |
| 8 | MP0003195_calcinosis | 3.24601931 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.23329568 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.01880947 |
| 11 | MP0009840_abnormal_foam_cell | 3.01850745 |
| 12 | MP0005083_abnormal_biliary_tract | 2.76361175 |
| 13 | MP0005332_abnormal_amino_acid | 2.54760804 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.34718546 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.28517458 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.28096734 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.27765802 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.27609533 |
| 19 | MP0002254_reproductive_system_inflammat | 1.98020656 |
| 20 | MP0000609_abnormal_liver_physiology | 1.82897625 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.80446786 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.78454891 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.74438838 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.67653070 |
| 25 | MP0003868_abnormal_feces_composition | 1.65036351 |
| 26 | MP0004272_abnormal_basement_membrane | 1.57014869 |
| 27 | MP0004043_abnormal_pH_regulation | 1.51976224 |
| 28 | MP0000604_amyloidosis | 1.49669442 |
| 29 | MP0004264_abnormal_extraembryonic_tissu | 1.37403801 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35731696 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.35479723 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.32934753 |
| 33 | MP0001764_abnormal_homeostasis | 1.29507952 |
| 34 | MP0003122_maternal_imprinting | 1.27611212 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.26092965 |
| 36 | MP0003186_abnormal_redox_activity | 1.24489212 |
| 37 | MP0001756_abnormal_urination | 1.19326169 |
| 38 | MP0003123_paternal_imprinting | 1.19085766 |
| 39 | MP0009764_decreased_sensitivity_to | 1.18181671 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.17255794 |
| 41 | MP0003879_abnormal_hair_cell | 1.11904656 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.11248530 |
| 43 | MP0000566_synostosis | 1.07292046 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.03039410 |
| 45 | * MP0008469_abnormal_protein_level | 1.02803430 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.01014409 |
| 47 | MP0003172_abnormal_lysosome_physiology | 0.99975659 |
| 48 | MP0004130_abnormal_muscle_cell | 0.99136996 |
| 49 | MP0000598_abnormal_liver_morphology | 0.99063788 |
| 50 | MP0003436_decreased_susceptibility_to | 0.97975977 |
| 51 | MP0002136_abnormal_kidney_physiology | 0.95521146 |
| 52 | MP0005451_abnormal_body_composition | 0.95359815 |
| 53 | MP0005166_decreased_susceptibility_to | 0.94396605 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.92040018 |
| 55 | MP0005670_abnormal_white_adipose | 0.90934684 |
| 56 | MP0001765_abnormal_ion_homeostasis | 0.90097126 |
| 57 | MP0009763_increased_sensitivity_to | 0.88060649 |
| 58 | MP0009697_abnormal_copulation | 0.87494832 |
| 59 | MP0005409_darkened_coat_color | 0.87234683 |
| 60 | * MP0009642_abnormal_blood_homeostasis | 0.87131461 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 0.83202442 |
| 62 | MP0002876_abnormal_thyroid_physiology | 0.82745606 |
| 63 | MP0003950_abnormal_plasma_membrane | 0.81417526 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.81176383 |
| 65 | MP0003075_altered_response_to | 0.80957423 |
| 66 | MP0003690_abnormal_glial_cell | 0.80403203 |
| 67 | MP0001915_intracranial_hemorrhage | 0.80023459 |
| 68 | MP0005408_hypopigmentation | 0.79271643 |
| 69 | MP0003303_peritoneal_inflammation | 0.78115394 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 0.77704994 |
| 71 | MP0002089_abnormal_postnatal_growth/wei | 0.76914046 |
| 72 | MP0005535_abnormal_body_temperature | 0.73364185 |
| 73 | MP0005376_homeostasis/metabolism_phenot | 0.73028500 |
| 74 | MP0005334_abnormal_fat_pad | 0.72734275 |
| 75 | MP0005464_abnormal_platelet_physiology | 0.72404425 |
| 76 | MP0002132_abnormal_respiratory_system | 0.72334378 |
| 77 | MP0005023_abnormal_wound_healing | 0.72112360 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.71160494 |
| 79 | MP0002971_abnormal_brown_adipose | 0.70703836 |
| 80 | MP0008004_abnormal_stomach_pH | 0.70693136 |
| 81 | MP0010368_abnormal_lymphatic_system | 0.70622464 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 0.70327144 |
| 83 | * MP0006082_CNS_inflammation | 0.70322236 |
| 84 | MP0001661_extended_life_span | 0.69669418 |
| 85 | MP0010386_abnormal_urinary_bladder | 0.69120138 |
| 86 | MP0005448_abnormal_energy_balance | 0.69020945 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.68538003 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.67722763 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.67088745 |
| 90 | MP0005257_abnormal_intraocular_pressure | 0.67088687 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.66481360 |
| 92 | MP0001881_abnormal_mammary_gland | 0.66180395 |
| 93 | MP0002928_abnormal_bile_duct | 0.65803766 |
| 94 | MP0001663_abnormal_digestive_system | 0.63567989 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.63109416 |
| 96 | MP0003941_abnormal_skin_development | 0.62414683 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.61894100 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.61115366 |
| 99 | MP0003283_abnormal_digestive_organ | 0.61092349 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.61048246 |
| 101 | MP0002419_abnormal_innate_immunity | 0.60921298 |
| 102 | MP0004782_abnormal_surfactant_physiolog | 0.60816729 |
| 103 | MP0003329_amyloid_beta_deposits | 0.60676247 |
| 104 | MP0005165_increased_susceptibility_to | 0.58295688 |
| 105 | MP0005310_abnormal_salivary_gland | 0.58033150 |
| 106 | MP0009785_altered_susceptibility_to | 0.57888950 |
| 107 | MP0004947_skin_inflammation | 0.57630984 |
| 108 | MP0005647_abnormal_sex_gland | 0.56789323 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.56612099 |
| 110 | MP0005395_other_phenotype | 0.56433061 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.56300651 |
| 112 | MP0001944_abnormal_pancreas_morphology | 0.55393653 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.54151091 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.54071111 |
| 115 | MP0005266_abnormal_metabolism | 0.53978829 |
| 116 | MP0004883_abnormal_blood_vessel | 0.53109696 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.52809130 |
| 118 | MP0001664_abnormal_digestion | 0.52788583 |
| 119 | MP0000462_abnormal_digestive_system | 0.52746845 |
| 120 | MP0003953_abnormal_hormone_level | 0.52523245 |
| 121 | MP0005330_cardiomyopathy | 0.52043444 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.51823978 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.51594987 |
| 124 | MP0005164_abnormal_response_to | 0.50330442 |
| 125 | MP0003724_increased_susceptibility_to | 0.50078043 |
| 126 | MP0003566_abnormal_cell_adhesion | 0.50071263 |
| 127 | MP0002090_abnormal_vision | 0.49688347 |
| 128 | MP0004147_increased_porphyrin_level | 0.49623268 |
| 129 | MP0002168_other_aberrant_phenotype | 0.49536534 |
| 130 | MP0001270_distended_abdomen | 0.48286499 |
| 131 | MP0000477_abnormal_intestine_morphology | 0.47918423 |
| 132 | MP0002796_impaired_skin_barrier | 0.46760161 |
| 133 | MP0010352_gastrointestinal_tract_polyps | 0.43347446 |
| 134 | MP0006054_spinal_hemorrhage | 0.41171589 |
| 135 | MP0005367_renal/urinary_system_phenotyp | 0.41162928 |
| 136 | MP0000516_abnormal_urinary_system | 0.41162928 |
| 137 | MP0003718_maternal_effect | 0.39947185 |
| 138 | MP0004270_analgesia | 0.38646476 |
| 139 | MP0000678_abnormal_parathyroid_gland | 0.36889158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.50788985 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.44999866 |
| 3 | Xanthomatosis (HP:0000991) | 5.26294191 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.04883610 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.96254668 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.71233070 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.38773214 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.28932653 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.15099595 |
| 10 | Epidermoid cyst (HP:0200040) | 3.85722067 |
| 11 | Complement deficiency (HP:0004431) | 3.77660649 |
| 12 | Fat malabsorption (HP:0002630) | 3.74143422 |
| 13 | Hypolipoproteinemia (HP:0010981) | 3.71487540 |
| 14 | Hyperammonemia (HP:0001987) | 3.70639543 |
| 15 | Ketosis (HP:0001946) | 3.67693540 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.67159783 |
| 17 | Joint hemorrhage (HP:0005261) | 3.63704986 |
| 18 | Hyperglycinuria (HP:0003108) | 3.63042397 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 3.60571038 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.57834250 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.45033430 |
| 22 | Hypercholesterolemia (HP:0003124) | 3.31770043 |
| 23 | Ketoacidosis (HP:0001993) | 3.31357922 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.31279161 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.26662797 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.25547431 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.25547431 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 3.24474158 |
| 29 | Hyperglycinemia (HP:0002154) | 3.21906766 |
| 30 | Abnormality of purine metabolism (HP:0004352) | 3.20551741 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.18044146 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.12274385 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.12115641 |
| 34 | Gout (HP:0001997) | 3.06709782 |
| 35 | Myocardial infarction (HP:0001658) | 3.05563052 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.95983969 |
| 37 | Mitral stenosis (HP:0001718) | 2.89937805 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 2.87418745 |
| 39 | Skin nodule (HP:0200036) | 2.87346524 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.86339308 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85369008 |
| 42 | Abnormality of complement system (HP:0005339) | 2.81686351 |
| 43 | Abnormal tarsal ossification (HP:0008369) | 2.76990205 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.74027836 |
| 45 | Hydroxyprolinuria (HP:0003080) | 2.73524052 |
| 46 | Abnormality of proline metabolism (HP:0010907) | 2.73524052 |
| 47 | Esophageal varix (HP:0002040) | 2.72041425 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.71370941 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71370941 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.65346480 |
| 51 | Malnutrition (HP:0004395) | 2.63907346 |
| 52 | Steatorrhea (HP:0002570) | 2.62642061 |
| 53 | Abnormality of vitamin metabolism (HP:0100508) | 2.61683586 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.59655686 |
| 55 | Rickets (HP:0002748) | 2.58970617 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.56635121 |
| 57 | Nephritis (HP:0000123) | 2.55374280 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.54692410 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52211447 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52211447 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52211447 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.51878325 |
| 63 | Abnormality of carpal bone ossification (HP:0006257) | 2.51155136 |
| 64 | Metabolic acidosis (HP:0001942) | 2.50756910 |
| 65 | Vascular calcification (HP:0004934) | 2.50621088 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.46855335 |
| 67 | Hypophosphatemic rickets (HP:0004912) | 2.46749855 |
| 68 | Sensorimotor neuropathy (HP:0007141) | 2.39194767 |
| 69 | Glomerulonephritis (HP:0000099) | 2.37905854 |
| 70 | Nausea (HP:0002018) | 2.36724292 |
| 71 | Flat acetabular roof (HP:0003180) | 2.36407091 |
| 72 | Menorrhagia (HP:0000132) | 2.33310313 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.32429863 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32429863 |
| 75 | Glycosuria (HP:0003076) | 2.30119851 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.30119851 |
| 77 | Lethargy (HP:0001254) | 2.29591658 |
| 78 | Widely patent fontanelles and sutures (HP:0004492) | 2.28938329 |
| 79 | Acanthocytosis (HP:0001927) | 2.27799310 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.27630504 |
| 81 | Proximal tubulopathy (HP:0000114) | 2.25613475 |
| 82 | Pancreatitis (HP:0001733) | 2.25539601 |
| 83 | Ileus (HP:0002595) | 2.24903806 |
| 84 | Axonal loss (HP:0003447) | 2.24180587 |
| 85 | Hyperuricemia (HP:0002149) | 2.21919838 |
| 86 | Increased purine levels (HP:0004368) | 2.21919838 |
| 87 | Cardiovascular calcification (HP:0011915) | 2.17648725 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15575528 |
| 89 | Focal segmental glomerulosclerosis (HP:0000097) | 2.15184532 |
| 90 | Hyperphosphaturia (HP:0003109) | 2.15091656 |
| 91 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.15003543 |
| 92 | Vomiting (HP:0002013) | 2.14413776 |
| 93 | Potter facies (HP:0002009) | 2.14325811 |
| 94 | Facial shape deformation (HP:0011334) | 2.14325811 |
| 95 | Late onset (HP:0003584) | 2.14290081 |
| 96 | Delayed CNS myelination (HP:0002188) | 2.13284264 |
| 97 | Osteomalacia (HP:0002749) | 2.11113921 |
| 98 | Irritability (HP:0000737) | 2.11057850 |
| 99 | Hyperglycemia (HP:0003074) | 2.10942013 |
| 100 | Hypothermia (HP:0002045) | 2.10737599 |
| 101 | Pigmentary retinal degeneration (HP:0001146) | 2.09695708 |
| 102 | Abnormality of serum amino acid levels (HP:0003112) | 2.08730376 |
| 103 | Alkalosis (HP:0001948) | 2.05985494 |
| 104 | Palpitations (HP:0001962) | 2.03967481 |
| 105 | Cerebral edema (HP:0002181) | 2.02895208 |
| 106 | Amyloidosis (HP:0011034) | 2.02218741 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01389450 |
| 108 | Abnormal urine phosphate concentration (HP:0012599) | 2.01160761 |
| 109 | Abdominal distention (HP:0003270) | 2.00455762 |
| 110 | Glomerulosclerosis (HP:0000096) | 2.00086497 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 1.97599288 |
| 112 | Gingival bleeding (HP:0000225) | 1.97473052 |
| 113 | Global brain atrophy (HP:0002283) | 1.97303934 |
| 114 | Protuberant abdomen (HP:0001538) | 1.97285324 |
| 115 | Spastic diplegia (HP:0001264) | 1.96447269 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95666172 |
| 117 | Joint swelling (HP:0001386) | 1.94844971 |
| 118 | Hypotension (HP:0002615) | 1.91281664 |
| 119 | Cholelithiasis (HP:0001081) | 1.90973764 |
| 120 | Symptomatic seizures (HP:0011145) | 1.90608720 |
| 121 | Increased cerebral lipofuscin (HP:0011813) | 1.90107823 |
| 122 | Spontaneous abortion (HP:0005268) | 1.89507692 |
| 123 | Abnormal hand bone ossification (HP:0010660) | 1.85333571 |
| 124 | Purpura (HP:0000979) | 1.81542082 |
| 125 | Hypophosphatemia (HP:0002148) | 1.79550146 |
| 126 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78521048 |
| 127 | Abnormality of vitamin B metabolism (HP:0004340) | 1.78498606 |
| 128 | Abnormality of the Achilles tendon (HP:0005109) | 1.76288775 |
| 129 | Exocrine pancreatic insufficiency (HP:0001738) | 1.74098095 |
| 130 | Abnormal ossification of hand bones (HP:0005921) | 1.70984093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.51599317 |
| 2 | BCKDK | 3.55174068 |
| 3 | MST1R | 3.18517270 |
| 4 | ERN1 | 3.16292088 |
| 5 | TAOK3 | 3.02489211 |
| 6 | MAPK15 | 2.68764988 |
| 7 | ACVR1B | 2.65030030 |
| 8 | PBK | 2.56227295 |
| 9 | MAP3K12 | 2.48971463 |
| 10 | MST4 | 2.26772519 |
| 11 | LMTK2 | 2.15614549 |
| 12 | ERBB4 | 2.12329851 |
| 13 | PTK6 | 2.09681424 |
| 14 | MAP3K2 | 2.01569730 |
| 15 | FGFR4 | 2.01363069 |
| 16 | PKN2 | 2.00334535 |
| 17 | INSRR | 2.00155119 |
| 18 | TRIB3 | 1.90794131 |
| 19 | IRAK3 | 1.71422419 |
| 20 | CASK | 1.68261626 |
| 21 | TBK1 | 1.66857467 |
| 22 | RIPK4 | 1.65830735 |
| 23 | SIK1 | 1.63862029 |
| 24 | BCR | 1.63835486 |
| 25 | EPHA2 | 1.60147514 |
| 26 | WNK4 | 1.51415192 |
| 27 | RIPK1 | 1.51227919 |
| 28 | TYK2 | 1.48265450 |
| 29 | MAP3K14 | 1.40060042 |
| 30 | ICK | 1.36765940 |
| 31 | WNK3 | 1.35694972 |
| 32 | PIK3CG | 1.30354459 |
| 33 | FGFR2 | 1.30060501 |
| 34 | ABL2 | 1.28350143 |
| 35 | NEK9 | 1.20654885 |
| 36 | MAP2K2 | 1.20485465 |
| 37 | NEK1 | 1.18771840 |
| 38 | MAP3K3 | 1.14549145 |
| 39 | CSK | 1.14444829 |
| 40 | PRKG2 | 1.13824966 |
| 41 | SCYL2 | 1.11306320 |
| 42 | MET | 1.08424533 |
| 43 | PTK2 | 1.06287343 |
| 44 | JAK2 | 1.05501544 |
| 45 | PHKG2 | 1.05153621 |
| 46 | PHKG1 | 1.05153621 |
| 47 | LATS1 | 1.04734036 |
| 48 | JAK1 | 1.02140604 |
| 49 | PAK4 | 1.00301740 |
| 50 | TTN | 0.99057654 |
| 51 | KSR2 | 0.98908908 |
| 52 | MYLK | 0.97230459 |
| 53 | STK39 | 0.96804697 |
| 54 | FGFR1 | 0.96293144 |
| 55 | EIF2AK3 | 0.93296517 |
| 56 | AKT3 | 0.92439401 |
| 57 | FER | 0.88857894 |
| 58 | MAP2K6 | 0.86281192 |
| 59 | TRPM7 | 0.83270970 |
| 60 | GRK6 | 0.82844177 |
| 61 | MAP2K1 | 0.82324933 |
| 62 | NUAK1 | 0.81678160 |
| 63 | EPHB1 | 0.80994855 |
| 64 | BMX | 0.80847304 |
| 65 | OXSR1 | 0.80755393 |
| 66 | STK24 | 0.79545491 |
| 67 | TESK1 | 0.78832037 |
| 68 | MAP3K1 | 0.78720352 |
| 69 | ERBB2 | 0.77578671 |
| 70 | DDR2 | 0.76121760 |
| 71 | PDPK1 | 0.74433146 |
| 72 | CAMK2G | 0.72476202 |
| 73 | PRKAA2 | 0.72242044 |
| 74 | NME2 | 0.71639596 |
| 75 | PDK2 | 0.71506275 |
| 76 | FLT3 | 0.71412684 |
| 77 | PAK3 | 0.71218129 |
| 78 | DAPK2 | 0.71129313 |
| 79 | MAPK11 | 0.70957613 |
| 80 | STK38L | 0.70363583 |
| 81 | MAP3K9 | 0.69300431 |
| 82 | TNIK | 0.68419650 |
| 83 | MAP2K4 | 0.64440058 |
| 84 | LATS2 | 0.63231097 |
| 85 | MAP3K13 | 0.61832327 |
| 86 | MAP3K11 | 0.59641468 |
| 87 | EGFR | 0.59370497 |
| 88 | LIMK1 | 0.59300186 |
| 89 | NLK | 0.59088563 |
| 90 | CDK6 | 0.57910449 |
| 91 | IRAK1 | 0.57663750 |
| 92 | EIF2AK1 | 0.57396617 |
| 93 | WNK1 | 0.57077478 |
| 94 | ARAF | 0.55841217 |
| 95 | CAMK2D | 0.54693013 |
| 96 | IKBKE | 0.54221754 |
| 97 | STK38 | 0.54178105 |
| 98 | EPHA4 | 0.51205840 |
| 99 | DAPK1 | 0.51192790 |
| 100 | DYRK1B | 0.49811615 |
| 101 | GSK3A | 0.48311184 |
| 102 | PDK3 | 0.47669112 |
| 103 | PDK4 | 0.47669112 |
| 104 | CDK12 | 0.47045508 |
| 105 | GRK1 | 0.46948038 |
| 106 | CDK8 | 0.46103300 |
| 107 | CAMK1D | 0.45665303 |
| 108 | PRKACG | 0.45565500 |
| 109 | ERBB3 | 0.45117677 |
| 110 | MAP3K5 | 0.44593160 |
| 111 | PRKCE | 0.44152717 |
| 112 | TGFBR2 | 0.43847560 |
| 113 | FGR | 0.43353932 |
| 114 | MAP3K7 | 0.43171527 |
| 115 | PIK3CA | 0.41841766 |
| 116 | BRSK2 | 0.41582157 |
| 117 | PRKCQ | 0.41479733 |
| 118 | MAP3K6 | 0.41106657 |
| 119 | MAP2K3 | 0.40935945 |
| 120 | PDK1 | 0.40087599 |
| 121 | PRKAA1 | 0.39542292 |
| 122 | IRAK4 | 0.39186149 |
| 123 | PRKCZ | 0.38865407 |
| 124 | MATK | 0.38182090 |
| 125 | LRRK2 | 0.37753741 |
| 126 | SRC | 0.37060740 |
| 127 | ABL1 | 0.36441612 |
| 128 | RET | 0.36160597 |
| 129 | PRKG1 | 0.35377634 |
| 130 | MELK | 0.35096771 |
| 131 | IGF1R | 0.34566341 |
| 132 | PDGFRA | 0.34123611 |
| 133 | EPHA3 | 0.33294530 |
| 134 | SGK3 | 0.31422301 |
| 135 | NTRK3 | 0.31033189 |
| 136 | OBSCN | 0.30605739 |
| 137 | SGK223 | 0.30148313 |
| 138 | SGK494 | 0.30148313 |
| 139 | MAPKAPK3 | 0.29840104 |
| 140 | PRKCA | 0.29665485 |
| 141 | PRKCD | 0.28851105 |
| 142 | FGFR3 | 0.28681408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.41747377 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.27062558 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.00403595 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83138263 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69905006 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49941209 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48832839 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45206607 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31960894 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26786834 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18345489 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18224050 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13674735 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02140174 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96284361 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93273364 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.88390541 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87959154 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.87902594 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82750162 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79695028 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.75748582 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.74284027 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74113986 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71817478 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.70589055 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.69933239 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68348570 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65650267 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58113473 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56007145 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41355792 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36779860 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35949852 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34326952 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33903314 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.31170408 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30894465 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30691845 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27528923 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22846266 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19609792 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18082330 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14995691 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12468085 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.10830462 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08720172 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04622500 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02208539 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00384321 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97985764 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95614734 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87147204 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.85649630 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84449098 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84036643 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83570087 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83361400 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80328003 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79963933 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78123899 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77677670 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75948700 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.74461503 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73797768 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71675173 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66858053 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63128635 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61899148 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56567136 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51276245 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51008987 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50767474 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.50356613 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41676250 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40531568 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40076484 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39958969 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39487983 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.37469086 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35448206 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34322706 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.33729527 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32047379 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32001144 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31723290 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31081687 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30617646 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27536653 |
| 90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26544510 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25329323 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.23878338 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22643004 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21589584 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20554235 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.19477694 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16077715 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.14216317 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.11668148 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.10776122 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.10695975 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10672956 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.08764704 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07288129 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.04781285 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.04374938 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03434090 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03409124 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.02283403 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0099884 |

